Espoo, Finland, 27 May 2021: Reference is made to the stock exchange release by Nordhealth AS ("Nordhealth" or the "Company") on 25 May 2021 regarding the successful completion of a private placement (the "Offering").

Charles MacBain, CEO of Nordhealth, has through his majority owned company Three Plus Group Luxembourg SA sold 6,373,500 class A shares at NOK 40.786 per share in the Offering. Following this transaction, Charles MacBain will hold 6,373,502 class A shares and 29,742,998 class B shares in Nordhealth through Three Plus Group Luxembourg SA.

Valter Pasanen, CFO of Nordhealth, has through his company Oy Pasanen & Co Oy sold 86,313 class A shares at NOK 40.786 per share in the Offering. Following this transaction, Valter Pasanen will hold 86,313 class A shares and 402,796 class B shares in Nordhealth through Oy Pasanen & Co Oy.

Janne Huttunen, Board Member and CPO Veterinary of Nordhealth, has sold 583,537 class A shares at NOK 40.786 per share in the Offering. Following this transaction, Janne Huttunen will hold 583,537 class A shares and 2,723,175 class B shares in Nordhealth.

Olli Venemies, Board Member and CEO Therapy of Nordhealth, has sold 154,920 class A shares at NOK 40.786 per share in the Offering. Following this transaction, Olli Venemies will hold 154,922 class A shares and 722,967 class B shares in Nordhealth.

Juha Huttunen, COO Veterinary of Nordhealth, has sold 154,922 class A shares at NOK 40.786 per share in the Offering. Following this transaction, Juha Huttunen will hold 154,921 class A shares and 722,966 class B shares in Nordhealth.

Please refer to the attached notifications of trading for further details.


Company in brief: A cloud-based healthcare SaaS company with a purpose

Nordhealth is a cloud-based healthcare SaaS company whose mission is to redefine digital healthcare. The Company’s products empower healthcare professionals to improve patient care, increase efficiency and expand their business. Since 2005, the Company has acquired and built cloud-based software for veterinary and therapeutic professionals and their patients, and now serves more than 30,000 professionals across 7,000 clinics and hospitals located in over 25 countries. Nordhealth has a solid footprint in the Nordic region and a growing presence internationally. The Company’s highly diversified customer base includes Tier 1 companies such as IVC Evidensia, AniCura, Coronaria, and Fysios. Nordhealth, is headquartered in Espoo, Finland. The Group is remote-first, with more than 140 employees working either remotely or from offices (collaboration hubs), serving a global customer base.


For further information, please contact: 

Charles MacBain, CEO 
charles.macbain@nordhealth.com 
+44 75 3903 2200

Valter Pasanen, CFO
valter.pasanen@nordhealth.com
+358 50 560 9286